Vericel Corp (VCEL)
48.35
+0.74
(+1.55%)
USD |
NASDAQ |
May 17, 16:00
48.30
-0.05
(-0.10%)
After-Hours: 20:00
Vericel Shareholders Equity (Quarterly): 233.90M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 233.90M |
December 31, 2023 | 225.95M |
September 30, 2023 | 204.38M |
June 30, 2023 | 198.93M |
March 31, 2023 | 193.98M |
December 31, 2022 | 192.27M |
September 30, 2022 | 177.84M |
June 30, 2022 | 174.82M |
March 31, 2022 | 172.48M |
December 31, 2021 | 170.46M |
September 30, 2021 | 156.78M |
June 30, 2021 | 151.09M |
March 31, 2021 | 140.21M |
December 31, 2020 | 134.26M |
September 30, 2020 | 114.63M |
June 30, 2020 | 107.60M |
March 31, 2020 | 110.45M |
December 31, 2019 | 111.09M |
September 30, 2019 | 96.99M |
June 30, 2019 | 88.54M |
March 31, 2019 | 103.06M |
December 31, 2018 | 102.23M |
September 30, 2018 | 94.48M |
June 30, 2018 | 90.60M |
March 31, 2018 | 20.94M |
Date | Value |
---|---|
December 31, 2017 | 22.54M |
September 30, 2017 | 16.74M |
June 30, 2017 | 13.97M |
March 31, 2017 | 15.50M |
December 31, 2016 | 24.71M |
September 30, 2016 | 11.39M |
June 30, 2016 | 17.11M |
March 31, 2016 | 19.23M |
December 31, 2015 | 22.13M |
September 30, 2015 | 26.41M |
June 30, 2015 | 30.24M |
March 31, 2015 | 31.70M |
December 31, 2014 | 35.64M |
September 30, 2014 | 37.78M |
June 30, 2014 | 2.785M |
March 31, 2014 | 3.769M |
December 31, 2013 | 3.894M |
September 30, 2013 | 4.95M |
June 30, 2013 | 1.841M |
March 31, 2013 | 6.304M |
December 31, 2012 | 9.513M |
September 30, 2012 | -24.64M |
June 30, 2012 | -20.71M |
March 31, 2012 | -21.72M |
December 31, 2011 | -12.97M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
88.54M
Minimum
Jun 2019
233.90M
Maximum
Mar 2024
157.83M
Average
163.62M
Median
Shareholders Equity (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 476.81M |
Arbutus Biopharma Corp | 114.64M |
Chimerix Inc | 174.10M |
Karyopharm Therapeutics Inc | -168.96M |
Y-mAbs Therapeutics Inc | 99.19M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 356.66M |
Total Liabilities (Quarterly) | 122.76M |
Current Ratio | 5.202 |